BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival.
about
BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy.Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia.A Robust Optimization Approach to Cancer Treatment under Toxicity Uncertainty.3-Aroyl-1,4-diarylpyrroles Inhibit Chronic Myeloid Leukemia Cell Growth through an Interaction with Tubulin.Mutations in the breakpoint cluster region-Abelson murine leukemia 1 gene in Brazilian patients with chronic myeloid leukemia
P2860
BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
BCR-ABL mutations in chronic m ...... bitors and impact on survival.
@en
type
label
BCR-ABL mutations in chronic m ...... bitors and impact on survival.
@en
prefLabel
BCR-ABL mutations in chronic m ...... bitors and impact on survival.
@en
P2093
P2860
P50
P1433
P1476
BCR-ABL mutations in chronic m ...... bitors and impact on survival.
@en
P2093
Alicia Helena Magarinos Bozzano
Carla Boquimpani
Carlos Sérgio Chiattone
Carmino Antonio De Souza
Carolina Pavlovsky
Eduardo E Cervera
Elena Beatriz Moiraghi
Eliana C M Miranda
Ernesto Mayta
Ilana Zalcberg
P2860
P304
P356
10.3109/07357907.2015.1065499
P577
2015-08-14T00:00:00Z